Is trans-l-Diaminocyclohexane oxalatoplatinum Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use trans-l-Diaminocyclohexane oxalatoplatinum? Is trans-l-Diaminocyclohexane oxalatoplatinum safe for nursing mother and child? Does trans-l-Diaminocyclohexane oxalatoplatinum extracts into breast milk? Does trans-l-Diaminocyclohexane oxalatoplatinum has any long term or short term side effects on infants? Can trans-l-Diaminocyclohexane oxalatoplatinum influence milk supply or can trans-l-Diaminocyclohexane oxalatoplatinum decrease milk supply in lactating mothers?
trans-l-Diaminocyclohexane oxalatoplatinum lactation summary
- DrLact safety Score for trans-l-Diaminocyclohexane oxalatoplatinum is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of trans-l-Diaminocyclohexane oxalatoplatinum may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that trans-l-Diaminocyclohexane oxalatoplatinum may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using trans-l-Diaminocyclohexane oxalatoplatinum .
- Usage of trans-l-Diaminocyclohexane oxalatoplatinum is in contradiction to breastfeeding hence if it is must to use trans-l-Diaminocyclohexane oxalatoplatinum and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About trans-l-Diaminocyclohexane oxalatoplatinum usage in lactation
Return to breastfeeding is likely safe when milk platinum levels are not measurables (30 days).
Alternate Drugs for Antineoplastic agents. ATC L01
Busulfan(Dangerous)
Cisplatin(Unsafe)
Cyclophosphamide(Dangerous)
Doxorubicin(Dangerous)
Etoposide(Dangerous)
Hydroxyurea(Low Risk)
Mercaptopurine(Safe)
Mitoxantrone(Dangerous)
Vincristine(Dangerous)
Methotrexate(Low Risk)
Imatinib(Unsafe)
Trastuzumab(Unsafe)
Bevacizumab(Low Risk)
Rituximab(Low Risk)
Alemtuzumab(Low Risk)
Fluorouracil(Dangerous)
Paclitaxel(Dangerous)
Carboplatin(Dangerous)
Cetuximab(Unsafe)
Brentuximab Vedotin(Low Risk)
Ipilimumab(Unsafe)
Everolimus(Unsafe)
Thioguanine(Dangerous)
Dacarbazine(Dangerous)
Vinorelbine(Dangerous)
Bleomycin(Dangerous)
Vinblastine(Dangerous)
Nivolumab(Unsafe)
Nilotinib(Unsafe)
Dasatinib(Unsafe)
Cladribine(Dangerous)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Capecitabine(Dangerous)
Docetaxel(Dangerous)
Carmustine(Dangerous)
Exemestane(Dangerous)
Gemcitabine(Dangerous)
Dactinomycin(Dangerous)
Epirubucin(Dangerous)
Fluorouracil Topical Solution(Low Risk)
Idarubicin-Hcl(Dangerous)
Ifosfamide(Dangerous)
Melphalan(Dangerous)
Mitomycin(Dangerous)
Oxaliplatin(Dangerous)
Pentostatin(Dangerous)
Procarbazine(Dangerous)
Teniposide(Dangerous)
Thiotepa(Dangerous)
Tretinoin Oral(Dangerous)
Vinorelbine Tartrate(Dangerous)
Imatinib Mesilate(Unsafe)
Altretamine(Dangerous)
Aminoglutethimide(Dangerous)
5-Aminolevulinic Acid(Low Risk)
Hydroxycarbamide(Low Risk)
Anastrozole(Dangerous)
Arsenic-Trioxide(Dangerous)
Asparaginase(Dangerous)
Bexarotene(Dangerous)
Cytarabine(Dangerous)
Chlorambucil(Dangerous)
Chlormethine(Dangerous)
Daunorubicin(Dangerous)
Rubidomycin(Dangerous)
Amethopterin(Low Risk)
Vincaleukoblastine(Dangerous)
Doxorubicin Hydrochloride(Dangerous)
Vlb(Dangerous)
Mechlorethamine(Dangerous)
Platinum Diamminodichloride(Unsafe)
4-Amino-10-methylfolic Acid(Low Risk)
5-ALA(Low Risk)
5-Fu(Dangerous)
6-Mercaptopurine(Safe)
6-Thiohypoxanthine(Safe)
6-Thioxopurine(Safe)
MTX(Low Risk)
Cytosine Arabinoside(Dangerous)
Daunomycin(Dangerous)
Actinomycin D(Dangerous)
Deoxycoformycin(Dangerous)